BPC-157 + TB-500 (Wolverine Stack) certificate of analysis: lot APL-BPCTB10-2607-02

Compound
BPC-157 + TB-500 (Wolverine Stack)
Lot
APL-BPCTB10-2607-02
Laboratory
Supplier lab
Test
purity · HPLC
Result
99.12%
Tested
15 July 2026
Covers stock
Not current stock

BPC-157 + TB-500 10 mg from batch APL-BPCTB10-2607-02 was analysed on 15 July 2026 and measured 99.12% combined purity across TB-500 and BPC-157 by HPLC / Mass Spectrometry, passing all 5 release tests.

Combined purity

99.12%

Components

TB-500, BPC-157

Result

All 5 tests passed

Tested

15 July 2026

Method

HPLC / Mass Spectrometry

Net content

10.17 mg

Independent verification

BPC-157 + TB-500 10 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 98.29% purity by UPLC-MS/MS, analysed 27 August 2026 on lot APL-BPCTB10-2608-01, net content BPC-157 10.48 mg, TB-500 10.19 mg, verification code OZ-HPLCMS-BJ29.

Issued by Ozcanium Analytics . Covers every vial size of this compound; each report opens as the laboratory issued it.

  • Third-Party Purity COA (PDF, opens in a new tab) 98.29% purity by UPLC-MS/MS · net content BPC-157 10.48 mg, TB-500 10.19 mg Analysed 27 August 2026 Verification code OZ-HPLCMS-BJ29

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Compound Mix

BPC-157 + TB-500

Lot Number

APL-BPCTB10-2607-02

Analysis Date

15 July 2026

Method

HPLC / Mass Spectrometry

Purity

99.12%

Net Content

10.17 mg

  • TB-500 5.08 mg
  • BPC-157 5.09 mg

Form

Lyophilised Powder

Manufactured

July 2026

Issued

16 July 2026

Document ID

APL-COA-BPCTB10-2607-02

Verification Code

Batch traceable

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

Components resolved at 2.96 min (TB-500, 46.16%), 3.24 min (BPC-157, 52.96%); combined peptide area 99.12%. No single impurity peak exceeds 0.34%.

Peak List

#Time (min)Area% AreaAssignment
12.73312,5280.180—
22.9573,200,83146.160TB-500
33.2393,671,96052.960BPC-157
43.42723,2850.340—
53.85817,7740.260—
65.1287,0560.100—

Analytical Results

TestSpecificationResultStatus
AppearanceWhite/Off-White Lyophilised PowderConformsPASS
Identity (MS)All components confirmedConfirmedPASS
Purity (HPLC)≥98.0% combined99.12%PASS
Total Peptide Content95–105%99.1%PASS
Endotoxins<0.5 EU/mg<0.25 EU/mgPASS

TB-500

PubChem CID: 16132341 · CAS Number: 77591-33-4

Formula: C212H350N56O78S · MW: 4963.4 g/mol · In this vial: 5.08 mg

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Monitored (m/z)Detected (m/z)Relative Intensity
828828.241
994993.691.14
12421241.852.53

Detection assignment: TB-500

Collected Mass Spectrum

Intensity ×10 7

BPC-157

PubChem CID: 9941957 · CAS Number: 137525-51-0

Formula: C62H98N16O22 · MW: 1419.5 g/mol · In this vial: 5.09 mg

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Monitored (m/z)Detected (m/z)Relative Intensity
474474.171.25
711710.772.89
14211420.491.05

Detection assignment: BPC-157

Collected Mass Spectrum

Intensity ×10 7

Verification Protocol

  • Identity confirmed separately for each component by mass spectrometry against its own expected ion channels.
  • Purity measured by HPLC as the combined area of every assigned component peak against all integrated impurity peaks.
  • Batch traceability: this document reports the lot number printed on the vial.
  • Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View BPC-157 + TB-500 in the catalogue · How to read this certificate

What this report shows

An HPLC purity result is the share of the detected signal that belongs to the main peptide peak. It does not confirm identity (that is mass spectrometry) and it is not net peptide content, which also counts water, counter-ions and salts in the vial.